엑시큐어(XCUR)는 NAS에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.23 (-8.89%), 시가총액 $20.65M.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
엑시큐어의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
엑시큐어의 현재 주가는 $1.23 (-8.89%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
엑시큐어의 시가총액은 약 $20.65M입니다.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets.